• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Reltecimod TFA

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5819777

Reltecimod (AB-103) TFA is an antagonist of the T-cell-specific surface glycoprotein CD28 (TP44), demonstrating efficacy against various bacterial infections, including their exotoxins and endotoxins, as well as ionizing radiation. By modulating the… More details

Please Inquire
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Reltecimod, Biochemical
Full Product Name
Reltecimod TFA
Product Synonym Names
AB-103 TFA
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Molecular Weight
1037.19 (free base)
Formula
C46H72N10O15S.xC2HF3O2
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
In_vitro
Reltecimod, administered intravenously at dosages ranging from 1.25 to 5 mg/kg, has been shown to enhance survival rates in mice infected with various bacteria [1].

Other Notes

Small volumes of Reltecimod biochemical vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Reltecimod purchase

MBS5819777 is a biochemical targeting Reltecimod. Also known as Reltecimod TFA.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000